Immutep Ltd ADR (NQ: IMMP )

3.605 USD +0.025 (+0.70%)

Streaming Delayed Price Updated: 2:48 PM EDT, Aug 4, 2021 Add to My Watchlist

Price and Volume

Volume	164,732
Open	3.640
Bid (Size)	3.600 (15)
Ask (Size)	3.610 (12)
Prev. Close	3.580
Today's Range	3.560 - 3.660
52wk Range	1.220 - 7.950
Shares Outstanding	487,630,938
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Immutep Quarterly Activities Report

July 13, 2021

Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC

July 06, 2021

Performance

YTD	+17.05%	+17.05%
1 Month	-8.73%	-8.73%
3 Month	+9.91%	+9.91%
6 Month	+21.79%	+21.79%
1 Year	+181.64%	+181.64%

More News

Immutep Completes a A$60 Million Placement to Expand its Clinical Development and Manufacturing Program into Late-Stage Settings

June 21, 2021

Immutep to Evaluate Efti in Triple Combination Therapy Phase I Study with Chemotherapy and an anti-PD-1 Therapy

June 21, 2021

Immutep Reveals a New Anti-LAG-3 Research Program

June 08, 2021

Immutep Reports Positive Final Data from the INSIGHT-004 Phase I Study of LAG-3 Therapy, Efti, at ASCO 2021

June 04, 2021

Immutep Reports Positive Data from its TACTI-002 Phase II Study of LAG-3 Therapy, Efti, at ASCO 2021

June 04, 2021

Immutep Secures Second European Patent For Eftilagimod Alpha, A Soluble LAG-3 Protein, In Combination With A PD-1 Pathway Inhibitor

June 02, 2021

Immutep Shares Are Trading Higher On Green Signal To Start Efti Combo Trial In First-Line Head & Neck Cancer

July 06, 2021

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

June 22, 2021

12 Health Care Stocks Moving In Monday's Pre-Market Session

June 21, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.